Türker Meltem, Sancar Mesut, Demirtunç Refik, Uçar Nazlıcan, Uzman Osman, Ay Pınar, Kozan Ömer, Okuyan Betul
Marmara University Faculty of Pharmacy, Department of Clinical Pharmacy, Istanbul, Turkey
University of Health Sciences Turkey, Haydarpasa Numune Training and Research Hospital, Clinic of Internal Medicine, Istanbul, Turkey
Turk J Pharm Sci. 2021 Sep 1;18(4):445-451. doi: 10.4274/tjps.galenos.2020.88319.
This study aimed to evaluate the validity and reliability of an oral anticoagulation knowledge (OAK) test in Turkish patients on warfarin therapy at an anticoagulant outpatient clinic.
This study was conducted at an ambulatory anticoagulation clinic and included patients older than 18 years who had been using warfarin for at least six months. Patients' demographic and clinical data were collected. Internal consistency was calculated using the Kuder-Richardson 20 (KR-20) coefficient, and the test-retest reliability of the Turkish version of the OAK test was assessed.
Patients' mean age was 59.83±11.93 (26-90) years (n=240; 133 women). The mean score of the OAK test was 14.19±3.01. The test-retest reliability of the scale (n=30) was moderate for the total score (p<0.001). The KR-20 value, a measure of internal consistency, was 0.671. Patients of a younger age and higher educational level were more likely to have higher levels of anticoagulation knowledge than patients of an older age and lower education level (p<0.05 for both comparisons).
The Turkish version of the OAK test can be used to determine the patients' knowledge on oral anticoagulation.
本研究旨在评估土耳其抗凝门诊接受华法林治疗患者的口服抗凝知识(OAK)测试的有效性和可靠性。
本研究在一家门诊抗凝诊所进行,纳入年龄大于18岁且使用华法林至少6个月的患者。收集患者的人口统计学和临床数据。使用库德-理查森20(KR-20)系数计算内部一致性,并评估OAK测试土耳其语版本的重测信度。
患者的平均年龄为59.83±11.93(26 - 90)岁(n = 240;133名女性)。OAK测试的平均得分为14.19±3.01。该量表(n = 30)总分的重测信度中等(p < 0.001)。作为内部一致性衡量指标的KR-20值为0.671。与年龄较大且教育程度较低的患者相比,年龄较小且教育程度较高的患者更有可能具有较高水平的抗凝知识(两项比较p均<0.05)。
OAK测试土耳其语版本可用于确定患者关于口服抗凝的知识。